AC Immune Ltd (ACIU) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.66x

AC Immune Ltd (ACIU) has a Cash Flow Reinvestment Rate of 0.66x as of December 2024, reinvesting $3.92 Million (capex $90.00K plus investments $-3.83 Million) from operating cash flow of $5.93 Million. See AC Immune Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.66x
(Capex + Investments) / Operating CF

Total Reinvested

$3.92 Million
Capex + Investments

Operating Cash Flow

$5.93 Million
USD

Capital Expenditures

$90.00K
USD

AC Immune Ltd Cash Flow Reinvestment Rate (2015–2024)

Historical reinvestment intensity for AC Immune Ltd across 3 annual periods. For the full cash flow conversion analysis, see ACIU cash generation efficiency.

Annual Cash Flow Reinvestment Rate for AC Immune Ltd (2015–2024)

Year-by-year capital reinvestment analysis for AC Immune Ltd. See AC Immune Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 1.61x $105.87 Million $65.84 Million $576.00K ▲ +29.1%
2019 1.25x $68.77 Million $55.22 Million $1.89 Million ▲ +83.0%
2015 0.68x $29.99 Million $44.08 Million $244.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow